The noble Lord is absolutely right about that. There is a history to this. The reason why there is a history is, first, that this is an eminently desirable place to arrive at, in that it would give us tremendous transparency in pricing. At the moment, it is extremely difficult to discern the pricing structures in the industry from the point of view of the payers. Secondly, it would enable us—and this is the objective—to arrive at the point where we could give patients the access to the medicines that are most appropriate to them.
Health Service Medical Supplies (Costs) Bill
Proceeding contribution from
Lord Lansley
(Conservative)
in the House of Lords on Monday, 23 January 2017.
It occurred during Debate on bills
and
Committee proceeding on Health Service Medical Supplies (Costs) Bill.
About this proceeding contribution
Reference
778 c71GC Session
2016-17Chamber / Committee
House of Lords Grand CommitteeSubjects
Librarians' tools
Timestamp
2021-10-12 15:12:06 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2017-01-23/1701242000188
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2017-01-23/1701242000188
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2017-01-23/1701242000188